Please provide your email address to receive an email when new articles are posted on . Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth ...

Please provide your email address to receive an email when new articles are posted on . Theragen has announced the issuance of a second U.S. patent for its ActaStim-S, a wearable and app-compatible ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company, is pleased to announce the North American Spine Society (NASS) has issued ...

JACKSONVILLE, Fla., Aug. 18, 2022 /PRNewswire/ -- Medical device company Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ...

Researchers from The Johns Hopkins University School of Medicine performed a systematic review and meta-analysis of published data on the effect of electrical stimulation therapies on spinal fusion.

DUBLIN--(BUSINESS WIRE)--The "Bone Growth Stimulator Market - Global Opportunity Analysis and Industry Forecast (2017-2022)" report has been added to Research and Markets' offering. Global bone growth ...

Researchers performed a systematic review and meta-analysis of published data on the effect of electrical stimulation therapies on spinal fusion. They found significant improvement overall in the ...

Spine surgeons in the U.S. perform more than 400,000 spinal fusions each year as a way to ease back pain and prevent vertebrae in the spine from wiggling around and doing more damage. However, reports ...